Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C11H10O6 |
| Molecular Weight | 238.1935 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)OC1=C(OC(C)=O)C(=CC=C1)C(O)=O
InChI
InChIKey=NYIZXMGNIUSNKL-UHFFFAOYSA-N
InChI=1S/C11H10O6/c1-6(12)16-9-5-3-4-8(11(14)15)10(9)17-7(2)13/h3-5H,1-2H3,(H,14,15)
| Molecular Formula | C11H10O6 |
| Molecular Weight | 238.1935 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Dipyrocetyl (2,3-diacetyloxybenzoic acid) is a drug used as an analgesics and antipyretics. Besides, was shown, that it may be useful in the treatment of acute lung injury (ALI) associated with acute respiratory distress syndrome (ARDS). Dipyrocetyl possesses the anticoagulation properties, which may contribute directly to improve tissue integrity as well as indirectly by the prevention of activation of pro-inflammatory cytokines. In addition, was made a suggestion, that the drug may function as an MMP inhibitor.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P08253 Gene ID: 4313.0 Gene Symbol: MMP2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/15123232 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | DIPYROCETYL Approved UseUnknown |
|||
| Primary | DIPYROCETYL Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:11:46 GMT 2025
by
admin
on
Mon Mar 31 18:11:46 GMT 2025
|
| Record UNII |
EF5UVE254C
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
N02BA79
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
||
|
WHO-ATC |
N02BA09
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
||
|
WHO-VATC |
QN02BA79
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
||
|
NCI_THESAURUS |
C257
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
||
|
WHO-VATC |
QM01BA02
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
||
|
WHO-VATC |
QN02BA09
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
||
|
WHO-ATC |
M01BA02
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
||
|
WHO-VATC |
QN02BA59
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
||
|
WHO-ATC |
N02BA59
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB13839
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
PRIMARY | |||
|
SUB07231MIG
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
PRIMARY | |||
|
486-79-3
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
PRIMARY | |||
|
CHEMBL1451173
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
PRIMARY | |||
|
EF5UVE254C
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
PRIMARY | |||
|
100000082356
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
PRIMARY | |||
|
C80542
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
PRIMARY | |||
|
207-641-7
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
PRIMARY | |||
|
645
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
PRIMARY | |||
|
3160
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
PRIMARY | |||
|
m1122
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
PRIMARY | Merck Index | ||
|
758212
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
PRIMARY | |||
|
68093
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
PRIMARY | |||
|
DTXSID9045976
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
PRIMARY | |||
|
Dipyrocetyl
Created by
admin on Mon Mar 31 18:11:46 GMT 2025 , Edited by admin on Mon Mar 31 18:11:46 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |